Olmesartan and hepatic function abnormal Patient Reports February 11, 2012

Olmesartan Side Effects Report #6062669-8
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Jan 15, 2009. Female patient, 73 years of age, was diagnosed with hypertension and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood bilirubin increased, hepatic function abnormal, jaundice . Olmesartan dosage: 10 MG,PER ORAL. During the same period patient was treated with NORVASC. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #6076239-9
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Jan 27, 2009. Female patient, 73 years of age, weighting 127.2 lb, was diagnosed with hypertension and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: autoimmune hepatitis, biliary cirrhosis primary, carbohydrate antigen 19-9 increased, cholelithiasis, hepatic cyst, hepatic function abnormal, liver disorder. Olmesartan dosage: 10 MG, PER ORAL. During the same period patient was treated with NORVASC. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #5782244-X
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on June 04, 2008. Female patient, 70 years of age, weighting 124.1 lb, was diagnosed with hypertension and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, gamma-glutamyltransferase increased, hepatic function abnormal. Olmesartan dosage: 10 MG, PER ORAL. During the same period patient was treated with BUFFERIN, LANDEL, MARZULENE S, GASMOTIN. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #5447436-8
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2007. Female patient, 61 years of age, was diagnosed with hypertension and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block, blood lactate dehydrogenase increased, electrocardiogram abnormal, gamma-glutamyltransferase increased, hepatic function abnormal, nausea , nodal rhythm. Olmesartan dosage: (10 MG), PER ORAL. During the same period patient was treated with NORVASC, TAUNUS AQUA SPRAY. Patient was hospitalized. Patient recovered.


Olmesartan Side Effects Report #5466243-3
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Sept 06, 2007. Female patient, 61 years of age, was diagnosed with hypertension and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrioventricular block, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, nausea , nodal rhythm. Olmesartan dosage: 10 MG (10 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with NORVASC, TAUNUS AQUA SPRAY. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #5502291-2
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Oct 12, 2007. Male patient, 60 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: blood pressure increased, hepatic function abnormal, liver disorder, no therapeutic response, paraesthesia, urine colour abnormal. Olmesartan dosage: 20 MG, PER ORAL. During the same period patient was treated with ACTOS, KINEX, AMARYL, BASTAMION, GOSHAJINKIGAN, TENORMIN. Patient recovered.

Olmesartan Side Effects Report #5519437-2
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2007. Male patient, 60 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anxiety , aspartate aminotransferase increased, blood pressure inadequately controlled, chromaturia, diabetes mellitus inadequate control, feeling abnormal, hepatic function abnormal, paraesthesia. Olmesartan dosage: 20 MG (20 MG, 1IN 1 D), PER ORAL. During the same period patient was treated with ACTOS, KINEX, AMARYL, BASTAMION, GOSHAJINKIGAN, TENORMIN, DAONIL, ADALAT. Patient recovered.

Olmesartan Side Effects Report #5574017-8
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Dec 12, 2007. Male patient, 60 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bilirubin conjugated increased, blood bilirubin increased, diverticulum, gastritis, hepatic function abnormal, jaundice , liver disorder. Olmesartan dosage: 20 MG (1 IN 1 D), PER ORAL. During the same period patient was treated with NORVASC, ACETYLSALICYLIC ACID SRT, ADONA, CARNACULIN. Patient was hospitalized. Patient recovered.

Olmesartan Side Effects Report #5727313-5
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on Apr 16, 2008. Male patient, 60 years of age, weighting 143.3 lb, was diagnosed with hypertension, prophylaxis and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: eye disorder, hepatic function abnormal, liver disorder, mucous membrane disorder, stevens-johnson syndrome. Olmesartan dosage: 20 MG (20 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with PLAVIX, HYDANTOL. Patient was hospitalized. Patient recovered.


Olmesartan Side Effects Report #5755229-7
Olmesartan side effect was reported by a Consumer or non-health professional from JAPAN on May 14, 2008. Male patient, 60 years of age, weighting 143.3 lb, was diagnosed with hypertension, prophylaxis and was treated with Olmesartan. After drug was administered, patient experienced the following side effects: hepatic function abnormal, liver disorder, stevens-johnson syndrome. Olmesartan dosage: 20 MG (20 MG, 1 IN 1 D), PER ORAL. During the same period patient was treated with PLAVIX, HYDANTOL. Patient was hospitalized. Patient recovered.